You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic cancers

Showing 1 - 25 of 5,952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Paris, France
    Tredaniel
May 18, 2022

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Hematologic Tumors Trial in Spain, United States (CC-90002, Rituximab)

Completed
  • Hematologic Neoplasms
  • Scottsdale, Arizona
  • +12 more
Aug 10, 2021

Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 7, 2022

Advanced Solid Cancers, Hematologic Cancers Trial in New York, San Antonio, Toronto (SRF231)

Completed
  • Advanced Solid Cancers
  • Hematologic Cancers
  • New York, New York
  • +2 more
Oct 19, 2020

Genomic Profiling in Cancer Patients

Recruiting
  • Solid Tumors
  • Hematologic Cancers
  • molecular profiling of tumors
  • Clinical Germline Analysis
  • Bridgeport, Connecticut
  • +17 more
Dec 28, 2022

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

CIBMTR Research Database

Recruiting
  • Autologous Stem Cell Transplantation
  • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 20, 2023

    Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

    Recruiting
    • Neoplasms
    • Birmingham, Alabama
    • +62 more
    Jan 19, 2023

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

    Recruiting
    • Acute Erythroid Leukemia
    • +10 more
    • San Francisco, California
    • +5 more
    Nov 1, 2022

    Hematologic Malignancy Trial in Oklahoma City (Blood and/or platelet transfusion, Complete blood count (CBC) collection)

    Recruiting
    • Hematologic Malignancy
    • Blood and/or platelet transfusion
    • Complete blood count (CBC) collection
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Oct 14, 2021

    Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

    Recruiting
    • Neoplasms
    • +2 more
    • La Jolla, California
    • +15 more
    Dec 7, 2022

    Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

    Recruiting
    • Solid Tumor
    • +11 more
    • Belfast, United Kingdom
    • +16 more
    Mar 2, 2023

    Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

    Recruiting
    • Acute Myelogenous Leukemia (AML)
    • +5 more
    • Conditioning Chemotherapy
    • Cord blood graft
    • Basking Ridge, New Jersey
    • +6 more
    May 22, 2023

    Hematologic Tumors Trial run by the NCI (Stem cell transplantation, Fludarabine, Cyclophosphamide)

    Completed
    Has Results
    • Hematologic Neoplasms
    • Stem cell transplantation
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 19, 2021

    Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

    Active, not recruiting
    • Beta-Thalassemia
    • +4 more
    • CTX001
    • Stanford, California
    • +11 more
    Nov 30, 2022

    Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • CTX001
    • Philadelphia, Pennsylvania
    • +3 more
    Jan 24, 2023

    Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Tumors Trial in Tampa (busulfan,

    Completed
    • Chronic Myeloproliferative Disorders
    • +4 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute at Universit
    Dec 9, 2020

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

    Active, not recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +6 more
    • Duarte, California
    • +8 more
    Jan 11, 2023

    Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

    Recruiting
    • Solid Tumor
    • +10 more
    • Belfast, United Kingdom
    • +25 more
    Mar 28, 2023

    Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

    Recruiting
    • Solid Tumor
    • +10 more
    • Belfast, United Kingdom
    • +25 more
    Mar 14, 2023

    Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

    Recruiting
    • Solid Tumor
    • +10 more
    • Belfast, United Kingdom
    • +25 more
    Mar 14, 2023

    Advanced Solid Tumors and Hematological Malignancies Trial (TQB2928 Injection)

    Not yet recruiting
    • Advanced Solid Tumors and Hematological Malignancies
    • TQB2928 Injection
    • (no location specified)
    Apr 21, 2021